(Q44069565)

29 November 2017

title

GM-1 Ganglioside for Spinal-Cord Injury (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM199202133260717

11 November 2022

author name string

Landi G

1

1 reference

29 November 2017

Ciccone A

2

1 reference

29 November 2017

Schönhöfer PS

1

1 reference

1732787

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1732787

11 November 2022

language of work or name

English

0 references

publication date

1 February 1992

1 reference

29 November 2017

13 February 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1732786

full work available at URL

11 November 2022

http://www.nejm.org/doi/pdf/10.1056/NEJM199202133260717

1 reference

https://api.crossref.org/works/10.1056/NEJM199202133260717

The New England Journal of Medicine

11 November 2022

published in

1 reference

29 November 2017

volume

326

1 reference

29 November 2017

issue

7

1 reference

29 November 2017

page(s)

493; author reply 494

1 reference

Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside

29 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1056/NEJM199202133260717

Critical review of gangliosides and thyrotropin-releasing hormone in peripheral neuromuscular diseases

11 November 2022

2

1 reference

https://api.crossref.org/works/10.1056/NEJM199202133260717

A double-blind, placebo-controlled trial of high doses of gangliosides in amyotrophic lateral sclerosis

11 November 2022

3

1 reference

https://api.crossref.org/works/10.1056/NEJM199202133260717

Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides.

11 November 2022

5

1 reference

https://api.crossref.org/works/10.1056/NEJM199202133260717

Motoneuron-disease-like disorder after ganglioside therapy

11 November 2022

7

1 reference

https://api.crossref.org/works/10.1056/NEJM199202133260717

11 November 2022

Acute spinal-cord injury

9

1 reference

https://api.crossref.org/works/10.1056/NEJM199202133260717

Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study

11 November 2022

10

1 reference

https://api.crossref.org/works/10.1056/NEJM199202133260717

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

11 November 2022

11

1 reference

https://api.crossref.org/works/10.1056/NEJM199202133260717

Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside

11 November 2022

12

1 reference

https://api.crossref.org/works/10.1056/NEJM199202133260717

The epidemiology of Guillain-Barré syndrome

11 November 2022

13

1 reference

https://api.crossref.org/works/10.1056/NEJM199202133260717

Ganglioside therapy and Guillain-Barré syndrome. A historical cohort study in Ferrara, Italy, fails to demonstrate an association

11 November 2022

14

1 reference

https://api.crossref.org/works/10.1056/NEJM199202133260717

Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside

11 November 2022

15

1 reference

https://api.crossref.org/works/10.1056/NEJM199202133260717

11 November 2022

Identifiers

1 reference

29 November 2017

1 reference